SCHEMBL6741176

SCHEMBL6741176

CSc1snc(-c2ccccc2)c1C#N

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 2/20 0.47
PPARG P37231 1/20 0.47
NCOR2 Q9Y618 1/20 0.47
ALDH1A1 P00352 5/20 0.46
KDM4E B2RXH2 3/20 0.46
LMNA P02545 1/20 0.46
GRIA4 P48058 1/20 0.46
ADORA1 P30542 8/20 0.44
ADORA2A P29274 6/20 0.44
MAPK1 P28482 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MAPT P10636 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
THRB P10828 1/20 0.41
PTPN1 P18031 1/20 0.41
PKM P14618 1/20 0.41
HTT P42858 1/20 0.40
GRM6 O15303 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11948735 0.78 ADORA1 (0.47) ALDH1A1KDM4ELMNAADORA1ADORA2A
SCHEMBL12285001 0.76 NPC1 (0.56) RXFP1ALDH1A1ADORA1ADORA2AMEN1
SCHEMBL5154549 0.75 ADORA1 (0.47) RXFP1ALDH1A1ADORA1ADORA2AMEN1
SCHEMBL5150675 0.75 ADORA1 (0.56) ADORA1ADORA2AGRM6HSD17B10ADORA2B
SCHEMBL19665219 0.71 RXFP1 (0.64) RXFP1PPARGNCOR2ALDH1A1KDM4E
SCHEMBL29349579 0.71 KMT2A (0.51) RXFP1PPARGNCOR2ALDH1A1KDM4E
SCHEMBL30852637 0.71 GRIA4 (0.46) ALDH1A1GRIA4ADORA1ADORA2AMEN1
SCHEMBL1808677 0.70 PLA2G1B (0.52) ALDH1A1KDM4EADORA1ADORA2AMAPT
SCHEMBL11443695 0.70 ALDH1A1 (0.47) ALDH1A1KDM4ELMNAGRIA4MAPK1
SCHEMBL5638835 0.70 ALDH1A1 (0.59) RXFP1ALDH1A1KDM4ELMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040023807-A1 3-Arylisothiazoles and their use as herbicides BASF AKTIENGESELLSCHAFT (DE) 2004-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040023807-A1 3-Arylisothiazoles and their use as herbicides DDT, HAX1, SULT1E1 RXFP1 341/4885PPARG 607/4885NCOR2 1661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.